Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.

Churcher TS, Pion SD, Osei-Atweneboana MY, Prichard RK, Awadzi K, Boussinesq M, Collins RC, Whitworth JA, Basáñez MG.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16716-21. doi: 10.1073/pnas.0906176106. Epub 2009 Sep 17.

2.

Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.

Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK.

Lancet. 2007 Jun 16;369(9578):2021-9.

PMID:
17574093
3.

Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.

Pion SD, Grout L, Kamgno J, Nana-Djeunga H, Boussinesq M.

Acta Trop. 2011 Sep;120 Suppl 1:S91-9. doi: 10.1016/j.actatropica.2010.05.004. Epub 2010 May 24.

4.

Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?

Frempong KK, Walker M, Cheke RA, Tetevi EJ, Gyan ET, Owusu EO, Wilson MD, Boakye DA, Taylor MJ, Biritwum NK, Osei-Atweneboana M, Basáñez MG.

Clin Infect Dis. 2016 Jun 1;62(11):1338-1347. doi: 10.1093/cid/ciw144. Epub 2016 Mar 21.

5.

Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis.

Basáñez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M.

Lancet Infect Dis. 2008 May;8(5):310-22. doi: 10.1016/S1473-3099(08)70099-9. Review.

PMID:
18471776
6.

Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.

Abegunde AT, Ahuja RM, Okafor NJ.

Cochrane Database Syst Rev. 2016 Jan 15;(1):CD011146. doi: 10.1002/14651858.CD011146.pub2. Review.

7.

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Pion SD, Nana-Djeunga HC, Kamgno J, Tendongfor N, Wanji S, Njiokou F, Prichard RK, Boussinesq M.

PLoS Negl Trop Dis. 2013;7(2):e2084. doi: 10.1371/journal.pntd.0002084. Epub 2013 Feb 28.

8.

An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, Osei-Atweneboana MY, Lazdins-Helds JK, Ardrey AE, Addy ET, Quartey BT, Ahmed K, Boatin BA, Soumbey-Alley EW.

Ann Trop Med Parasitol. 2004 Apr;98(3):231-49.

PMID:
15119969
10.

Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments.

Bottomley C, Isham V, Collins RC, Basáñez MG.

Parasitology. 2008 Nov;135(13):1571-81. doi: 10.1017/S0031182008000425. Epub 2008 Oct 3.

PMID:
18831801
11.

Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Lazdins-Helds JK, Ahmed K, Boatin BA, Boakye DA, Edwards G.

Ann Trop Med Parasitol. 2004 Jun;98(4):359-70.

PMID:
15228717
12.

River blindness.

Unnasch TR.

Lancet. 2002 Jul 20;360(9328):182-3. No abstract available.

PMID:
12133647
13.

Ten years of NGDO action against river blindness.

Drameh PS, Richards FO, Cross C, Etya'alé DE, Kassalow JS.

Trends Parasitol. 2002 Sep;18(9):378-80. Review.

PMID:
12377246
14.

Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.

Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue, Duke BO.

Lancet. 2002 Jul 20;360(9328):203-10.

PMID:
12133654
15.

Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus.

Eng JK, Blackhall WJ, Osei-Atweneboana MY, Bourguinat C, Galazzo D, Beech RN, Unnasch TR, Awadzi K, Lubega GW, Prichard RK.

Mol Biochem Parasitol. 2006 Dec;150(2):229-35. Epub 2006 Sep 8.

PMID:
17007942
16.
17.

Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.

Katabarwa MN, Eyamba A, Nwane P, Enyong P, Yaya S, Baldiagaï J, Madi TK, Yougouda A, Andze GO, Richards FO.

Am J Trop Med Hyg. 2011 Dec;85(6):1041-9. doi: 10.4269/ajtmh.2011.11-0333.

18.

One in the eye for river blindness.

Taylor M.

Trends Parasitol. 2001 Aug;17(8):358. No abstract available.

PMID:
11685890
19.

The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.

Awadzi K, Opoku NO, Attah SK, Addy ET, Duke BO, Nyame PK, Kshirsagar NA.

Ann Trop Med Parasitol. 1997 Apr;91(3):281-96.

PMID:
9229021
20.

Onchocerciasis (river blindness). Report from the fifteenth InterAmerican Conference on Onchocerciasis, Caracas, Venezuela.

[No authors listed]

Wkly Epidemiol Rec. 2006 Jul 28;81(30):293-6. English, French. No abstract available.

PMID:
16874924

Supplemental Content

Support Center